iRhythm Holdings, Inc. Restructuring Costs and Asset Impairment Charges
iRhythm Holdings, Inc. (IRTC) reported Restructuring Costs and Asset Impairment Charges of $641.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2025-02-20
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for the quarter ending 2023-12-31 was $11.08M.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for the quarter ending 2023-09-30 was $0.00.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for the quarter ending 2023-06-30 was $0.00.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for fiscal 2024 was $641.00K, a 94.21% decline from fiscal 2023.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for fiscal 2023 was $11.08M, a 58.37% decline from fiscal 2022.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for fiscal 2022 was $26.61M.
- iRhythm Holdings, Inc. restructuring costs and asset impairment charges for fiscal 2021 was $0.00.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2024-12-31 | $641.00K 10-K · filed 2025-02-20 | |||
| 2023-12-31 | $11.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $11.08M derived: sum of 2 quarters · filed 2025-02-20 | $11.08M derived: sum of 3 quarters · filed 2025-02-20 | $11.08M 10-K · filed 2025-02-20 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $0.00 derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $0.00 derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $26.61M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $26.61M 10-Q · filed 2023-11-02 | $26.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $26.61M 10-Q · filed 2023-08-04 | $26.61M derived: sum of 3 quarters · filed 2024-02-22 | $26.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $26.61M 10-Q · filed 2023-05-04 | $26.61M derived: sum of 2 quarters · filed 2024-02-22 | $26.61M derived: sum of 3 quarters · filed 2024-02-22 | $26.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |